RECENT ASSET RESEARCH REPORTS
February 5th, 2020 - RIO TINTO
January 26th, 2020 - LINX SA
December 29th, 2019 - MPLX LP
December 23rd, 2019 - WPP Group
December 16th, 2019 - Energy Transfer
December 10th, 2019 - Heineken
December 10th, 2019 - Sandstorm GOLD
December 5th, 2019 - SGX
November 29th, 2019 - Ehang 216
November 16th, 2019 - Royal Vopak
November 5th, 2019 - BAM Groep NV
October 25th, 2019 - Equinor
October 17th, 2019 - Netflix
October 5th, 2019 - Adyen
September 12th, 2019 - ABN AMRO
September 4th, 2019 - Norsk Hydro
August 27th, 2019 - Tesla
August 19th, 2019 - Phantasm.io
August 13th, 2019 - Abbvie
August 5th, 2019 - Sensetime
OUR STORY
Hatchworks is a venture firm with an in-house incubator. The company thoroughly vets, invests in and monitors its portfolio investments through an Investment Committee (IC) and Operations Committee (OC). Hatchnet, which is its proprietary algorithmic investment insight platform is now open to all HATCHTOKEN holders, giving early access and insight on industry leading VC deals that have eluded the masses for decades. While VCs keep the best deals to themselves, we share, through our upcoming series of Hatchfunds.
OUR COMPANIES
Through our network of investment companies, over $4m has been invested in over 70 target assets around the world. Below are just a few of our investments.
Stage: IPO
ROI: 22%
Beyond Meat is disrupting the meat-production industry by offering a plant-based alternative.
Stage: Listed
ROI: 250%
Binance Binance is the world's largest trading exchange for digital currencies.
Stage: Listed, Bond
ROI: 10.1%
Anheuser-Buschis a global alcoholic beverages conglomerate behind some of the biggest beverage brands in the world.
Stage: Listed, Bond
ROI: 9.57%
Nestle is one of the world's biggest food and beverage producing conglomerates operating through over 2000 brands.
Stage: Seed
ROI: 52% (WATP)
Spectre.ai Spectre.ai is a cutting edge broker-less financial trading platform whose tokens have outperformed the bear market.
Stage: Listed
ROI: 22%
Abbvie AbbVie is an American biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
OUR TEAM
Our highly experienced Investment Committee (IC) and Operations Committee (OC) is comprised of veteran investment bankers from JP Morgan, Goldman Sachs and successful entrepreneurs who have had successful exits. All investments, whether or not they are early-stage seed investments or later stage growth capital, go through a strict quantitative (Hatchscore) and qualitative assessment process before which term sheets are studied from a deal mechanics and legal perspective. Positions are then entered and portfolio construction is conducted carefully , taking into account asset-specific valuations and correlation on a sector and cross-portfolio basis, as well.
CONTACT
If you are an entrepreneur, member of the press or future token holder and wish to get in touch with us, you can reach us using the contact information provided below. Please allow 24 hours for a response.
Address: HW Global Ltd. Raffles Place, #40-02, One Raffles Place, Office Tower 1, Singapore 048616
Contact: